A potential role for immune activation in hemodialysis hypotension

Renal Failure

Volumn 23, Issue 5, 2001, Pages 637-649

  Tomita, M ^a   Malhotra, D ^a   Dheenan, S ^a   Shapiro, J I ^a   Henrich, W L ^a   Santoro, T J ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HEMODIALYSIS; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; IMMUNE SYSTEM; IMMUNOGENICITY; MALE; MEAN ARTERIAL PRESSURE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOTENSION; IMMUNITY; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0035164306     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100107360     Document Type: Article

References (41)

1. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients
2. Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1 beta levels and different dialysis membranes
3. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: Which cytokine is a surrogate marker for dialysis-related complications?
4. Elevated serum levels of C-reactive protein in hemodialysis patients
5. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
6. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
7. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction
8. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
9. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6
10. Cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression
11. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements
12. Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter
13. Cytokine production and cytotoxicity of lymphocytes in patients on maintenance short- or long-term haemodialysis
14. Non-endotoxinic tumour necrosis factor-alpha-inducing factors in haemodialysis
15. Gene expression of interleukin-1 beta during hemodialysis
16. Enhancement of in-vitro human interleukin-1 production by sodium acetate
17. Combined report on regular dialysis and transplantation in Europe, VIII, 1977
18. Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS)
19. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis
20. Production of cytokines and cytokine inhibitory proteins in patients on dialysis
21. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System
22. Dialysis therapy
23. Enhanced production of nitric oxide may involved in acute hypotension during maintenance hemodyalysis
24. Nitric oxide synthases in mammals
25. Nitric oxide: Physiology, pathophysiology, and pharmacology
26. Regulation of biosynthesis of nitric oxide
27. Role of nitric oxide in hemodialysis hypotension
28. Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension
29. Increased nitric oxide production in patients with hypotension during hemodialysis
30. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells
31. Nitric oxide and its role in the cardiovascular system
32. Hypotension during hemodialysis: Role for nitric oxide
33. Plasma endothelin levels in patients with uremia
34. Increased body fluid purine levels during hypotensive events. Evidence for ATP degradation
35. Role of adenosine in dialysis-induced hypotension
36. Differential nitric oxide production by microvascular and macrovascular endothelial cells
37. Molecular cloning and characterization of human endothelial nitric oxide synthase
38. Regulation of expression of the endothelial cell nitric oxide synthase
39. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase
40. Cyclic strain causes heterogeneous induction of transcription factors, AP-1, CRE binding protein and NF-kB, in endothelial cells: Species and vascular bed diversity
41. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress